NIAID Banner Logo Image

HIV Citation List: August 15 - August 28, 2014

PubMed citations

1. Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection. Barton, K.M., N.M. Archin, K.S. Keedy, A.S. Espeseth, Y.L. Zhang, J. Gale, F.F. Wagner, E.B. Holson, and D.M. Margolis. PloS One, 2014. 9(8): p. e102684. PMID[25136952].

[PubMed]. HIV_0815-082814.


2. Pyridopyrimidinone Inhibitors of HIV-1 RNase H. Velthuisen, E.J., B.A. Johns, P. Gerondelis, Y. Chen, M. Li, K. Mou, W. Zhang, J.W. Seal, K.E. Hightower, S.R. Miranda, K. Brown, and L. Leesnitzer. European Journal of Medicinal Chemistry, 2014. 83: p. 609-616. PMID[24997293].

[PubMed]. HIV_0815-082814.


3. Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production. Lederle, A., B. Su, V. Holl, J. Penichon, S. Schmidt, T. Decoville, G. Laumond, and C. Moog. Scientific Reports, 2014. 4: p. 5845. PMID[25132382].

[PubMed]. HIV_0815-082814.


4. Functionalization, Cyclization and Antiviral Activity of A-Secotriterpenoids. Grishko, V.V., N.V. Galaiko, I.A. Tolmacheva, I.I. Kucherov, V.F. Eremin, E.I. Boreko, O.V. Savinova, and P.A. Slepukhin. European Journal of Medicinal Chemistry, 2014. 83: p. 601-608. PMID[24997292].

[PubMed]. HIV_0815-082814.


5. Azvudine, a Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-resistant Strains Than Lamivudine in vitro. Wang, R.R., Q.H. Yang, R.H. Luo, Y.M. Peng, S.X. Dai, X.J. Zhang, H. Chen, X.Q. Cui, Y.J. Liu, J.F. Huang, J.B. Chang, and Y.T. Zheng. PloS One, 2014. 9(8): p. e105617. PMID[25144636].

[PubMed]. HIV_0815-082814.


6. Aqueous Extracts of the Marine Brown Alga Lobophora variegata Inhibit HIV-1 Infection at the Level of Virus Entry into Cells. Kremb, S., M. Helfer, B. Kraus, H. Wolff, C. Wild, M. Schneider, C.R. Voolstra, and R. Brack-Werner. PloS One, 2014. 9(8): p. e103895. PMID[25144758].

[PubMed]. HIV_0815-082814.


7. Antiretroviral Activity of Metal-chelating HIV-1 Integrase Inhibitors. Carcelli, M., D. Rogolino, M. Sechi, G. Rispoli, E. Fisicaro, C. Compari, N. Grandi, A. Corona, E. Tramontano, C. Pannecouque, and L. Naesens. European Journal of Medicinal Chemistry, 2014. 83: p. 594-600. PMID[24996145].

[PubMed]. HIV_0815-082814.


8. Anti-HIV Activities of Precisely Defined, Semirigid, Carboxylated Alternating Copolymers. Savage, A.M., Y. Li, L.E. Matolyak, G.F. Doncel, S.R. Turner, and R.D. Gandour. Journal of Medicinal Chemistry, 2014. 57(15): p. 6354-6363. PMID[25026140].

[PubMed]. HIV_0815-082814.

ISI Web of Knowledge Citations

9. Small Molecule Inhibition of SAMHD1 dNTPase by Tetramer Destabilization. Seamon, K.J., E.C. Hansen, A.P. Kadina, B.A. Kashemirov, C.E. McKenna, N.N. Bumpus, and J.T. Stivers. Journal of the AmericanChemical Society, 2014. 136(28): p. 9822-9825. ISI[000339228200007].

[WOS]. HIV_0815-082814.


10. Optimization of the Antiviral Potency and Lipophilicity of Halogenated 2,6-Diarylpyridinamines as a Novel Class of HIV-1 NNRTIS. Wu, Z.Y., N. Liu, B.J. Qin, L. Huang, F. Yu, K.D. Qian, S.L. Morris-Natschke, S.B. Jiang, C.H. Chen, K.H. Lee, and L. Xie. ChemMedChem, 2014. 9(7): p. 1546-1555. ISI[000338991100023].

[WOS]. HIV_0815-082814.


11. Minocycline Attenuates HIV-1 Infection and Suppresses Chronic Immune Activation in Humanized NOD/LTSZ-Scidil-2R-gamma(null) Mice. Singh, M., P. Singh, D. Vaira, M. Amand, S. Rahmouni, and M. Moutschen. Immunology, 2014. 142(4): p. 562-572. ISI[000339662900005].

[WOS]. HIV_0815-082814.


12. Anti-HIV Activities in an African Plant Extract. Zheng, Y., M. Mulinge, M. Counson, X. Yang, A. Steinmetz, J.C. Schmit, and C. Devaux. Planta Medica, 2014. 80(10): p. 804-804. ISI[000339781200252].

[WOS]. HIV_0815-082814.


13. A New Activity for SAMHD1 in HIV Restriction. Yang, Z.Y. and W.C. Greene. Nature Medicine, 2014. 20(8): p. 808-809. ISI[000340074600007].

[WOS]. HIV_0815-082814.


14. The anti-HIV Activity of Flavonoids: Quercetin and Pinocembrin. Murata, R.M., S. Pasetto, and V. Pardi. Planta Medica, 2014. 80(10): p. 811-811. ISI[000339781200285].

[WOS]. HIV_0815-082814


15. A Cell-intrinsic Inhibitor of HIV-1 Reverse Transcription in CD4(+) T Cells from Elite Controllers. Leng, J., H.P. Ho, M.J. Buzon, F. Pereyra, B.D. Walker, X.G. Yu, E.J. Chang, and M. Lichterfeld. Cell Host & Microbe, 2014. 15(6): p. 717-728. ISI[000339944300010].

[WOS]. HIV_0815-082814.


16. Synthesis and Studies of Biological Activity of New 8-{(Adamant-1-yl)alkyl amino}theophylline Derivatives. Valuev-Elliston, V.T., E.N. Savel'ev, A.V. Ivanov, B.S. Orlinson, E.N. Gerasimov, E.K. Zakharova, L.L. Brunilina, S.N. Kochetkov, I.A. Novakov, and M.B. Navrotskii. Russian Chemical Bulletin, 2013. 62(11): p. 2544-2546. ISI[000339729700038].

[WOS]. HIV_0815-082814.

Patent Citations

17. Preparation of Macroheterocyclic Compounds for the Treatment of Viral Infections. Bondy, S.S., C.E. Cannizzaro, C.-H. Chou, Y.E. Hu, J.O. Link, Q. Liu, S.D. Schroeder, W.C. Tse, and J.R. Zhang. Patent. 2014. 2014-US10937 2014110296: 108pp.

[Patent]. HIV_0815-082814.


18. Preparation of 5-Membered Heteroaryl Compounds Useful in Treatment of Viral Infections. Bondy, S.S., C.E. Cannizzaro, C.-H. Chou, J.O. Link, Q. Liu, S.D. Schroeder, W.C. Tse, and J.R. Zhang. Patent. 2014. 2014-US10939 2014110298: 93pp.

[Patent]. HIV_0815-082814.


19. Preparation of (Hetero)Arylacetamide Derivatives as Antiretroviral Agents. Brizgys, G., C.-H. Chou, R.L. Halcomb, Y.E. Hu, Q. Liu, J.R. Somoza, W.C. Tse, and J.R. Zhang. Patent. 2014. 2014-US10938 2014110297: 156pp.

[Patent]. HIV_0815-082814.


20. Quinolone Derivative Containing Pyrimidine Ring, and Preparation Method and Use Thereof for Resisting HIV-1 Infection. Chen, F., Q. He, T. Mao, and Z. Wan. Patent. 2014. 2014-10201093 103965163: 17pp.

[Patent]. HIV_0815-082814.


21. Pyridinotriazinone Derivatives as HIV Integrase Inhibitors and Their Preparation. Embrey, M.W., T.H. Graham, A. Walji, S.T. Waddell, T. Yu, Y. Zhang, W. Liu, P.J. Coleman, J. Wai, T. Steele, and C. Di Marco. Patent. 2014. 2013-US74590 2014099586: 106pp.

[Patent]. HIV_0815-082814.


22. Preparation of Polycyclic-carbamoylpyridone Compounds and Their Pharmaceutical Use. Jin, H., S.E. Lazerwith, T.A.T. Martin, E.M. Bacon, J.J. Cottell, Z.R. Cai, H.-J. Pyun, P.A. Morganelli, M. Ji, J.G. Taylor, X. Chen, M.R. Mish, and M.C. Desai. Patent. 2014. 2013-US76367 2014100323: 261pp.

[Patent]. HIV_0815-082814.


23. Preparation of Substituted Spiropyrido[1,2-a]pyrazine Derivative and Medicinal Use Thereof as HIV Integrase Inhibitors. Miyazaki, S., H. Isoshima, K. Oshita, S. Kawashita, N. Nagahashi, and M. Terashita. Patent. 2014. 2013-JP85059 2014104279: 340pp.

[Patent]. HIV_0815-082814.


24. Preparation of Novel Betulinic acid proline Derivatives as HIV Inhibitors. Panduranga Reddy, A., B. Parthasaradhi Reddy, K. Rathnakar Reddy, L. Subrahmanyam VI, G.L. David Krupadanam, M. Venkati, N. Sudhakar, and K. Srinivas Reddy. Patent. 2014. 2013-US77751 2014105926: 151pp.

[Patent]. HIV_0815-082814.


25. Anti-cancer and anti-HIV Compounds. Usui, I., J.N. Beverage, and V.R.R. Macherla. Patent. 2014. 2014-US14668 2014123900: 168pp.

[Patent]. HIV_0815-082814.


26. Application of Antiviral Compound in Preparing anti-HIV-1 Virus Drugs. Zhang, H., C. Bai, and T. Pan. Patent. 2014. 2014-10120259 103893172: 8pp.

[Patent]. HIV_0815-082814.


27. Preparation and Application of Non-Nucleoside S-Dabos Pyrimidone Derivatives with Action against HBV Virus, HIV Virus and HCV Virus. Zhang, L., Y. Fu, H. Qin, X. Wang, and J. Liu. Patent. 2014. 2012-10531716 103864699: 30pp.

[Patent]. HIV_0815-082814.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024